Brucella abortus-infected macrophages modulate T lymphocytes to promote osteoclastogenesis via IL-17

Am J Pathol. 2012 Sep;181(3):887-96. doi: 10.1016/j.ajpath.2012.05.029.

Abstract

The pathogenic mechanisms of bone loss caused by Brucella species have not been completely deciphered. Although T lymphocytes (LTs) are considered important to control infection, the mechanism of Brucella-induced T-cell responses to immunopathological features is not known. We present in vitro and in vivo evidence showing that Brucella abortus-induced inflammatory response leads to the activation of LTs, which further promote osteoclastogenesis. Pre-activated murine LTs treated with culture supernatant from macrophages infected with B. abortus induced bone marrow-derived monocytes (BMMs) to undergo osteoclastogenesis. Furthermore, osteoclastogenesis was mediated by CD4(+) T cells. Although B. abortus-activated T cells actively secreted the pro-osteoclastogenic cytokines RANKL and IL-17, osteoclastogenesis depended on IL-17, because osteoclast generation induced by Brucella-activated T cells was completely abrogated when these cells were cultured with BMMs from IL-17 receptor knockout mice. Neutralization experiments indicated that IL-6, generated by Brucella infection, induced the production of pro-osteoclastogenic IL-17 from LTs. By using BMMs from tumor necrosis factor receptor p55 knockout mice, we also demonstrated that IL-17 indirectly induced osteoclastogenesis through the induction of tumor necrosis factor-α from osteoclast precursors. Finally, extensive and widespread osteoclastogenesis was observed in the knee joints of mice injected with Brucella-activated T cells. Our results indicate that activated T cells, elicited by B. abortus-infected macrophages and influenced by the inflammatory milieu, promote the generation of osteoclasts, leading to bone loss.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Marrow Cells / metabolism
  • Bone Marrow Cells / pathology
  • Brucella abortus / immunology*
  • Brucellosis / immunology
  • Brucellosis / microbiology
  • CD4-Positive T-Lymphocytes / immunology
  • Cells, Cultured
  • Interleukin-17 / biosynthesis
  • Interleukin-17 / metabolism*
  • Interleukin-6 / metabolism
  • Lymphocyte Activation / immunology
  • Macrophages / immunology
  • Macrophages / metabolism
  • Macrophages / microbiology*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Osteoclasts / immunology*
  • Osteoclasts / metabolism
  • Osteogenesis / immunology*
  • RANK Ligand / metabolism
  • Receptors, Interleukin-17 / metabolism
  • Receptors, Tumor Necrosis Factor, Type I / deficiency
  • Receptors, Tumor Necrosis Factor, Type I / metabolism
  • Subcellular Fractions / metabolism
  • T-Lymphocytes / immunology*
  • Tibia / immunology
  • Tibia / pathology
  • Tumor Necrosis Factor Decoy Receptors / deficiency
  • Tumor Necrosis Factor Decoy Receptors / metabolism
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Interleukin-17
  • Interleukin-6
  • RANK Ligand
  • Receptors, Interleukin-17
  • Receptors, Tumor Necrosis Factor, Type I
  • Tumor Necrosis Factor Decoy Receptors
  • Tumor Necrosis Factor-alpha
  • recombinant human tumor necrosis factor-binding protein-1